Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disulfide bonds are covalent linkages formed between cysteine residues in lens proteins, primarily crystallins. While contributing to protein stability and structure, aberrant formation or exchange is implicated in age-related changes and cataract formation. These bonds can be formed co-translationally or post-translationally under oxidative stress, leading to protein aggregation and lens opacification. Therapeutic strategies may target the prevention or disruption of aberrant disulfide linkages.
Disulfide bond disruptors (potential therapeutic)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disulfide Bond in Lens Protein.